Authors
Loading...
Observational cohort study shows serial monitoring of fusion transcript predicts minimal residual disease in CBF-AML, indicating risk stratification for relapse.
Ohanian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: